checkAd
    Startseite > Aktien > Carmell Corporation > Nachrichten
    Carmell Corporation Aktie
    2,4900
     
    USD
    +1,63 %
    +0,0400 USD
    Letzter Kurs 01.06.24 Nasdaq
    2,2500
     
    USD
    400 STK
    Geldkurs 31.05.24
    2,5700
     
    USD
    300 STK
    Briefkurs 31.05.24
    ISIN: US1429221039 · WKN: A3ENXR · SYM: CTCX · USA

    Neueste Nachrichten

    Carmell Announces Successful Closing of $3.0 Million Private Placement
    11.04.24 · globenewswire · Carmell Corporation
    Carmell Announces $3.0 Million Private Placement
    04.04.24 · globenewswire · Carmell Corporation
    Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction
    27.03.24 · globenewswire · Carmell Corporation
    Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary
    20.03.24 · globenewswire · Carmell Corporation
    Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field
    18.03.24 · globenewswire · Carmell Corporation
    Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024
    26.02.24 · globenewswire · Carmell Corporation
    Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors
    16.11.23 · globenewswire · Carmell Corporation
    Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics
    06.09.23 · globenewswire · Carmell Corporation
    Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity
    09.08.23 · Business Wire (engl.) · Carmell Corporation
    Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
    27.07.23 · Business Wire (engl.) · Carmell Corporation
    Alpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics Corporation
    14.07.23 · Business Wire (engl.) · Carmell Corporation
    Alpha Healthcare Acquisition Corp. III Announces Non-Binding Letter of Intent to Acquire a Commercial Stage Regenerative Medicine Company Conditioned Upon Closing of Carmell Business Combination
    27.06.23 · Business Wire (engl.) · Carmell Corporation